Siwei Wang

3.9k citations
68 papers · 2.6k indexed · 2 hit papers · h-index 24

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Circular RNAs in diseases
    • RNA modifications and cancer

Papers in

    • Cancer-related molecular mechanisms research 13
    • Cancer Genomics and Diagnostics 10
    • MicroRNA in disease regulation 6
    • Lung Cancer Treatments and Mutations 12
    • Lung Cancer Diagnosis and Treatment 6
    • Ferroptosis and cancer prognosis 5

Siwei Wang

63 papers receiving 2.6k citations

Hit Papers

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma 2022 · 114 citations
1142019202620212023200400600

Peers

Siwei Wang
Comparison fields: 5 of 120
  • Cancer Research 1.2k
  • Molecular Biology 1.6k
  • Oncology 640
  • Immunology 363
  • Pulmonary and Respiratory Medicine 396
Replace Guolin Li with:
Guolin Li China
Kris Ylaya United States
Nan Zhu China
Pengfei Yu China
Qian Lei China
Bo Ma China
Bruno Costa‐Silva Portugal
Jianfei Huang China
Renbing Jia China
Je–Ho Lee South Korea
Siwei Wang relative to Guolin Li China Guolin Li's profile →
Citations per field
00.5×1.5×2.5×
Guolin Li · 1×
Citations per year

Countries citing papers authored by Siwei Wang

Since Specialization
Citations

This map shows the geographic impact of Siwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Wang more than expected).

Fields of papers citing papers by Siwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Wang. The network helps show where Siwei Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Siwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Siwei Wang Line = papers co-authored together Siwei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20242
4 20242
5 202453
6 202329
7 202332
8 202312
9 20233
10 20237
11 202312
12 202243
13 202126
14 202133
15 202111
16 202151
17 201915
18 20191
19 2018215
20 201861

About Siwei Wang

Siwei Wang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Immunology, having authored 68 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (13 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (10 papers), MicroRNA in disease regulation (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.6k citations), Oncology (640 citations), Immunology (363 citations) and Pulmonary and Respiratory Medicine (396 citations). Siwei Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Rong Yin, Lin Xu, Zhifei Ma, Chencheng Han, Panqi Fang, Tongyan Liu, Wenjia Xia, Mantang Qiu, Youtao Xu and Gaochao Dong. Their work appears in journals such as Nature Communications, Cancer Letters, Scientific Reports, Cancer Communications and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026